JNJ - Johnson & Johnson

NYSE - NYSE Delayed Price. Currency in USD
139.46
+2.90 (+2.12%)
At close: 4:00PM EDT

139.46 0.00 (0.00%)
After hours: 4:15PM EDT

Stock chart is not supported by your current browser
Previous Close136.56
Open136.23
Bid139.48 x 2900
Ask139.50 x 1100
Day's Range136.21 - 140.00
52 Week Range118.62 - 148.32
Volume8,031,029
Avg. Volume6,248,913
Market Cap374.138B
Beta (3Y Monthly)0.53
PE Ratio (TTM)277.26
EPS (TTM)0.50
Earnings DateOct 11, 2016 - Oct 17, 2016
Forward Dividend & Yield3.60 (2.69%)
Ex-Dividend Date2018-08-27
1y Target Est145.16
Trade prices are not sourced from all markets
  • STOCKS on the move: Netflix, Facebook, McDonald's, J&J, Home Depot, IBM
    Yahoo Finance Video5 hours ago

    STOCKS on the move: Netflix, Facebook, McDonald's, J&J, Home Depot, IBM

    Live from the floor of the New York Stock Exchange, Yahoo Finance's Jared Blikre joins Alexis Christoforous to discuss the latest market moves.

  • Stocks can keep rallying as long as Fed doesn't keep push...
    CNBC Videos21 hours ago

    Stocks can keep rallying as long as Fed doesn't keep push...

    Jim Cramer explains what led the market to soar on Tuesday after days of selling and says the strength can last if the Fed behaves accordingly.

  • Cramer: As long as the Fed doesn't keep pushing rate hike...
    CNBC Videos22 hours ago

    Cramer: As long as the Fed doesn't keep pushing rate hike...

    Jim Cramer explains what led the market to soar on Tuesday after days of selling and says the strength can last if the Fed behaves accordingly.

  • Thomson Reuters StreetEvents33 minutes ago

    Edited Transcript of JNJ earnings conference call or presentation 16-Oct-18 12:30pm GMT

    Q3 2018 Johnson & Johnson Earnings Call

  • Stock Market News For Oct 17, 2018
    Zacks6 hours ago

    Stock Market News For Oct 17, 2018

    Wall Street rebounded on Tuesday as stocks surged across the board due to strong third-quarter 2018 earnings results and impressive economic data.

  • ACCESSWIRE8 hours ago

    Today's Research Reports on Trending Tickers: vTv Therapeutics and Johnson & Johnson

    NEW YORK, NY / ACCESSWIRE / October 17, 2018 / U.S. equities closed higher on Tuesday, driven by upbeat corporate earnings and strong economic data. According to the Federal Reserve, U.S. industrial production ...

  • Asian shares climb on strong US corporate earnings, data
    Associated Press16 hours ago

    Asian shares climb on strong US corporate earnings, data

    SINGAPORE (AP) — Asian markets rose on Wednesday as robust U.S. corporate earnings and encouraging data assuaged worries about softening global growth.

  • TheStreet.com19 hours ago

    The Rally We've Been Waiting For: Cramer's 'Mad Money' Recap (Tuesday 10/16/18)

    "When the Fed bears are away, the stock bulls will play," Jim Cramer told his Mad Money viewers Tuesday, after the markets mounted an impressive relief rally. Cramer reminded viewers that a panic is a terrible thing to waste, which is why the smart money was buying into the recent declines and not selling out of fear.

  • The Wall Street Journal20 hours ago

    [$$] Prescription Drugs Power Johnson & Johnson Results

    Johnson & Johnson reported higher revenue and profit for the third quarter, as improved pharmaceutical sales helped offset weakness in its medical-device business. Global sales of J&J’s cancer drugs, which include Zytiga for prostate cancer and blood-cancer treatments Darzalex and Imbruvica, jumped 36% for the quarter. “Our positive view on pharma is offset by ongoing challenges to the company’s medical device and consumer franchises,” JPMorgan analyst Chris Schott wrote in a research note.

  • The Wall Street Journal20 hours ago

    [$$] Encouraging Test Results for Health-Care Giants

    Another round of strong earnings suggests that health care is living up to its reputation as a defensive industry. UnitedHealth Group and Johnson & Johnson, two industry heavyweights, demonstrated that with third-quarter results on Tuesday by topping analyst expectations on both the top and bottom line and increasing their full year profit guidance. UnitedHealth, the nation’s largest publicly traded health insurer, reported revenue of $56.5 billion and adjusted earnings of $3.41 a share.

  • TheStreet.com21 hours ago

    Jim Cramer: An Absence of Negatives Is a Real Positive

    This is what the market looks like when the Fed says nothing and the president isn't ranting about something involving Jay Powell or China. You wouldn't get this straight up move but as I explained in a video with Katherine Ross this morning, yesterday we hit minus seven on the S&P's proprietary oscillator, which is about as negative as we have gotten during this period and that means you have to find something to buy no matter what. Initially Walmart was down off of the numbers because they weren't adjusted for Flipkart but because everyone's so negative.

  • CNBC22 hours ago

    Cramer: As long as the Fed doesn't keep pushing rate hikes, stocks can keep rallying

    CNBC's Jim Cramer explains what led the market to soar on Tuesday after days of selling. The strength can last as long as the Fed doesn't get too hawkish, the "Mad Money" host warns. As better-than-expected earnings results drove the Dow Jones Industrial Average more than 500 points higher on Tuesday, paring last week's losses, CNBC's Jim Cramer became cautiously optimistic about the fate of the rally.

  • 3 Stocks for Warren Buffett Fans
    Motley Fool23 hours ago

    3 Stocks for Warren Buffett Fans

    If you want to be like Buffett, here's a healthcare stock, an auto company, and an airline for you.

  • What Happened in the Stock Market Today
    Motley Fool23 hours ago

    What Happened in the Stock Market Today

    Stocks bounced back, with investors encouraged by earnings reports from companies like Morgan Stanley and Johnson & Johnson.